HMy2.CIR [C1R, HMy2.C1R]人B淋巴细胞

HMy2.CIR细胞系来源于HMy.2b淋巴母细胞系，是ARH-77细胞系（ATCC-CRL-1621）的快速生长突变体，通过γ射线照射和HLAⅠ类抗原表达缺失的选择获得，据报道，CRL-1621细胞系对Epstein-Barr核抗原（EBNA+）和Epstein-Barr病毒衣壳抗原（EBVCA+）呈阳性；由于HMy2.CIR细胞系来源于HMy.2b淋巴母细胞系，一种ARH-77细胞系（ATCC-CRL-1621）的快速生长突变体，它被认为是EBNA阳性，细胞不表达HLA-A或B位点产物，但表达少量HLA-Cw4。

组织来源/Tissue and Cell Type ：外周血

形态/Morphology ：淋巴母细胞样  ，悬浮生长

培养基和添加剂/Complete Growth Medium and Culture Conditions：

90%IMDM(MD0700)+10%胎牛血清(SD0200)+G/A (SD0038)

完全培养基：IMDM完全培养基（货号：MD0701）

气相：空气，95%；二氧化碳，5%。 温度：37摄氏度。

冻存条件：基础培养基+5%DMSO+20%FBS

完全冻存液：免程序降温细胞冻存液（低血清）(SD0001)

注意事项：此产品仅供科研使用。

PubMed=3819393

Storkus W.J., Howell D.N., Salter R.D., Dawson J.R., Cresswell P.

NK susceptibility varies inversely with target cell class I HLA antigen expression.

J. Immunol. 138:1657-1659(1987)

PubMed=2784569; DOI=10.1073/pnas.86.7.2361

Storkus W.J., Alexander J., Payne J.A., Dawson J.R., Cresswell P.

Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.

Proc. Natl. Acad. Sci. U.S.A. 86:2361-2364(1989)

PubMed=1541831

Zemmour J., Little A.-M., Schendel D.J., Parham P.

The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.

J. Immunol. 148:1941-1948(1992)

PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001

Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R., Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K., Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D., Willis A., Askar M., Fischer G., Saw C.L., Ragoussis J., Petrek M., Serra-Pages C., Juan M., Stavropoulos-Giokas C., Dinou A., Ameen R., Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H., Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F., Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A., Fernandez-Vina M.A.

Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: report from the 17th International HLA and Immunogenetics Workshop.

Hum. Immunol. 80:449-460(2019)